The largest database of trusted experimental protocols

Fungizone

Manufactured by Thermo Fisher Scientific
Sourced in United States, United Kingdom, Germany, Belgium, France, Spain, Canada, Italy, Switzerland, New Zealand, Netherlands, Japan, Australia, Portugal, Austria, Brazil

Fungizone is a parenteral antifungal agent used for the treatment of serious and life-threatening fungal infections. It contains the active ingredient amphotericin B, a polyene antimicrobial compound that binds to ergosterol, a key component of fungal cell membranes, leading to increased permeability and cell death.

Automatically generated - may contain errors

942 protocols using fungizone

1

Establishment and Maintenance of Murine Oral and Pancreatic Cancer Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
The AT-84 oral cancer cell line is derived from a murine tumor of the oral mucosa that spontaneously arose in a C3H mice, it was originally isolated by Hier et al. [20 (link)] and was kindly provided by Dr Venuti A. and Dr Paolini F. [21 (link)] (Regina Elena National Cancer Institute, Rome, Italy). AT-84 cells were grown in RPMI-1640 medium (Life Technologies, Courtaboeuf, France) supplemented with 10% FCS (PAA), 100 U/mL penicillin (Life Technologies), 100 mg/mL streptomycin (Life Technologies) and 0.1% fungizone (Life Technologies). Cells were grown at 37 °C in a humidified atmosphere with 5% CO2.
The Hight TF-Panc02 cell line was derived from a pancreatic ductal adenocarcinoma induced in a C57BL/6 mouse1. This cell line is a subclone of Panc02 cells transfected with pcDNA 6.2-GW/EmGFP-miR mock described previously by Mezouar et al. [22 (link)]. Hight TF-Panc02 were grown in RPMI-1640 medium (Life Technologies) supplemented with 10% FCS (PAA), 100 U/mL penicillin (Life Technologies), 100 mg/mL streptomycin (Life Technologies) and 0.1% fungizone (Life Technologies). The cells were grown at 37 °C in a humidified atmosphere with 5% CO2.
+ Open protocol
+ Expand
2

Alveolar Organoid Formation from Murine Mammary Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mammary epithelial cells were isolated from 12- to 14-week-old nonparous mice and embedded (200 organoids per well) in Matrigel (BD Biosciences, San Jose, CA) in a 96-well plate, and allowed to solidify for 30 min. Organoid growth medium (150 μl per well, Dulbecco’s modified Eagle’s medium (DMEM)/F12, 5% fetal bovine serum, insulin-transferrin-sodium selenite (ITS) (Sigma Aldrich), gentamycin (50 µg/ml), penicillin/strepomycin, fungizone (Life Technologies, Carlsbad, CA, USA) was overlaid and incubated for 24 h. Alveologenesis medium (DMEM/F12, ITS, gentamycin (50 µg/ml), pen/strep, fungizone) including growth factors (9 nM FGF10 (Life Technologies), 9 nM bFGF, 9 nM TGFa, and 9 nM recombinant mouse prolactin (Sigma Aldrich)) was added, and replaced every third day. Images were captured on the seventh day after seeding.
+ Open protocol
+ Expand
3

Differentiation of Equine Mesenchymal Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Eight horses were used for differentiation experiments. For tenogenic control cultures, the cells were cultivated in expansion medium with a seeding density of 10,000 cells/cm2. The medium was renewed every 2–3 days and the cells were kept in a 5% CO2 environment at 37°C. To induce differentiation, we followed protocols established by others [22] . Briefly, to induce osteogenic differentiation, the cells were seeded at a density of 3,000 cells/cm2 and cultured in DMEM High Glucose with Glutamax (Life technologies), 10% FCS (Life technologies), 0.6% fungizone (Life technologies), 0.1% gentamicin (Life technologies) and freshly added 10 mM glycerol phosphate (Sigma-Aldrich), 0.1 μM dexamethasone (Sigma-Aldrich) and 0.1 mM L-ascorbic acid 2-phosphate (Sigma-Aldrich). To induce adipogenic differentiation cells were seeded at 20,000 cells/cm2 and the induction medium consisted of DMEM Glutamax (Life technologies) with 10% FCS (Life technologies), 0.6% fungizone (Life technologies), 0.1% gentamicin (Life technologies) and freshly added 0.1 μM dexamethasone (Sigma-Aldrich), 0.2 mM indomethacin (Sigma-Aldrich), 0.01 mg/ml insulin (Sigma-Aldrich) and 0.5 mM 3 iso-butyl-1-methyl-xanthine (Sigma-Aldrich). The cells were kept for 21 days in a 5% CO2 environment at 37°C and the differentiation media were refreshed twice a week.
+ Open protocol
+ Expand
4

Engineered Cartilage Tissue Analogs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Engineered cartilage tissue analogs (CTAs) were produced as described previously24 (link),25 . Briefly, articular cartilage was harvested from juvenile bovine knees (2–6 months old, Research 87, MA), finely minced, and digested overnight (12–16 hours) in DMEM containing collagenase Type II (298U/mL Worthington, NJ). Tissue digests were filtered (70µm pore mesh), washed with PBS containing 200U/mL penicillin, 200µg/mL streptomycin, 5µg/mL Fungizone (PSF, Life Technologies, NY), and centrifuged at 1750 rpm for 15 minutes at 12°C (3X) until collected into a single suspension. Chondrocytes were resuspended at 5×106 cells/mL in complete medium (high glucose DMEM containing 10% FBS, 100U/mL penicillin, 100µg/mL streptomycin, 2.5µg/mL Fungizone, 1% MEM Vitamin Solution (Gibco), 25mM HEPES buffer, 50µg/mL ascorbic acid25 ). This cell suspension was plated into ultra-low adhesion (polyHEMA coated) 96 well plates (Corning, NY) at 1×106 cells/well, where chondrocytes coalesced within 24 hours to form a CTA25 . CTAs were cultured for a minimum of 14–16 weeks in complete medium prior to injury.
+ Open protocol
+ Expand
5

Extraction and Conditioning of Degenerative IVD

Check if the same lab product or an alternative is used in the 5 most similar protocols
All procedures were performed with the approval of the Institutional Review Board of the University of Utah. Disc degeneration was classified using the Pfirrmann method (Table 1). Degenerative IVD tissue was extracted from the lumbar discs of five patients undergoing surgical intervention for axial back pain, and degenerative IVD conditioned media was produced using a previously described method.32 (link),40 (link) Briefly, surgical IVD tissue (containing both nucleus pulposus [NP] and AF tissue) was transferred into a glass petri dish, washed twice in washing medium (DMEM-HG (Life Technologies) supplemented with 1% gentamycin (Gibco), 1% kanamycin (Sigma-Aldrich), and 1% fungizone (Gibco)) and cut into small pieces (~3 mm2). Next, IVD tissue was weighed, and cultured in DMEM-HG supplemented with 50 μg/mL ascorbic acid (Life Technologies), 5 μg/mL gentamicin, and 0.125 μg/mL fungizone at a media to tissue ratio of 3.5 mL/g for 48 hours (37°C and 5% CO2).32 (link),40 (link) Following culture, degenerative IVD conditioned media from each individual patient were collected and stored separately by patient at −80°C, until time of experiments (up to 3 months).
+ Open protocol
+ Expand
6

Mammary Organoid Culture and Alveologenesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mammary epithelial cells were isolated from 12-14 week old nonparous mice and embedded (200 organoids/well) in Matrigel (BD Biosciences) in a 96 well plate, and allowed to solidify for 30 min. Organoid growth medium (150 μl/well, DMEM/F12, 5% FBS, ITS (Sigma Aldrich, St Louis, MO), gentamycin (50μg/mL), penicillin/strepomycin, fungizone (Life Technologies, Carlsbad, CA) was overlaid and incubated for 24 hours. Alveologenesis medium (DMEM/F12, ITS, gentamycin (50μg/mL), pen/strep, fungizone) including growth factors (9 nM FGF10(Life Technologies, Carlsbad, CA), 9 nM bFGF, 9 nM TGFa, and 9 nM recombinant mouse Prolactin (Sigma Aldrich, St Louis, MO)) was added, and replaced every third day. Images were captured on the seventh day after seeding.
+ Open protocol
+ Expand
7

C2C12 Myoblast Differentiation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
C2C12 cells were seeded to 8-well chamber slides coated with poly-ornithine (3 μg/mL) and laminin (10 μg/mL). Proliferating C2C12 myoblasts were maintained in high glucose Dulbecco’s modified eagle medium (DMEM, Life Technologies, Carlsbad, CA) containing 20% fetal bovine serum (Atlas Biologicals, Fort Collins, CO), 0.1% penicillin/streptomycin (Pen/Strep, Life Technologies, Carlsbad, CA), 2 mm glutamine (Life Technologies, Carlsbad, CA), and 0.1% Fungizone (Life Technologies, Carlsbad, CA) at 37°C and 5% CO2. Differentiation of C2C12 myoblasts into myotubes was achieved by seeding cells at a high density (5 × 108 cells/well) in DMEM containing 2% horse serum (Life Technologies, Carlsbad, CA), 0.1% Pen/Strep, 2 mm glutamine, and 0.1% Fungizone.
+ Open protocol
+ Expand
8

Isolation and culture of porcine VICs

Check if the same lab product or an alternative is used in the 5 most similar protocols
VICs were isolated from fresh porcine hearts (Hormel) as previously described (24 (link)). Aortic valve leaflets were removed and rinsed in a wash solution containing Earle’s Balanced Salt Solution (Life Technologies) with 1% penicillin-streptomycin (Life Technologies) and 0.5 μg/mL fungizone (Life Technologies). Then, the leaflets were incubated in 250 units/mL collagenase (Worthington) solution for 30 min. at 37°C and vortexed to remove endothelial cells. Cells were then incubated with collagenase solution for 60 min. at 37°C and vortexed. This solution was filtered with a 100 μm cell strainer and centrifuged. The cell pellet was resuspended in growth media consisting of Media 199 with 15% fetal bovine serum (FBS, Life Technologies), 2% penicillin-streptomycin (Life Technologies), and 0.5 μg/mL fungizone (Life Technologies). Cells were cultured at 37°C and 5% CO2 on tissue culture polystyrene (TCPS) for expansion before experiments. Cells were passaged using trypsin (Life Technologies) digestion. For experiments, media serum level was reduced to 10% FBS to reduce proliferation.
+ Open protocol
+ Expand
9

Isolation and Culture of Bovine Chondrocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
The fresh stifle joints from young adult cattle (15–24 months old) were obtained from a local abattoir (Bud’s Custom Meats, Riverside, IA). Articular cartilage was harvested from the femur condyle and rinsed in Hank’s Balanced Salt Solution (HBSS, Life Technologies, California, USA) supplemented with 100 U/μl penicillin, 100 μg/ml streptomycin, and 2.5 μg/μl fungizone (Invitrogen Life Technologies, Carlsbad, CA). Full-thickness cartilage samples were minced into fine pieces and then digested overnight with 0.25 mg/ml collagenase type I and pronase E (1:1) (Sigma-Aldrich, St. Louis, MO) dissolved in culture medium in a shaking incubator overnight (0.25 mg/ml each). After isolation, primary chondrocytes were re-plated and cultured in Dulbecco’s modified Eagle’s medium (DMEM) and Ham’s F12 (1:1 mixture) supplemented with 10% fetal bovine serum (Life Technologies, Grand Island, NY), 50 μg/μl L-ascorbate, 100 U/μl penicillin, 100 μg/ml streptomycin, and 2.5 μg/μl fungizone at 37 °C with 5% CO2.
+ Open protocol
+ Expand
10

Isolation of Cancer-Associated Fibroblasts

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tumour tissue was minced and transferred into a 10 cm culture dish. 10 ml of RPMI supplemented with 10% FCS, 1% fungizone (Life Technologies), 1% penicillin/streptomycin (Invitrogen) and activated collagenase 1A (1 mg/ml, Sigma) were added and incubated overnight at 37 °C. The digested tissue was then filtered through a cell strainer and centrifuged. The CAF-containing cell pellet was washed in PBS, resuspended in DMEM, 10% FBS, 1% P/S, 1% fungizone, and plated on collagen coated (35 μg/ml, rat tail collagen 1, Gibco) culture dish. Patient samples were obtained through NHS Greater Glasgow and Clyde Biorepository (project #305). All participants gave specific consent to use their tissue samples for research.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!